MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Neurobehavioral disorders"

  • 2019 International Congress

    Clinical and cognitive features of anxiety in Parkinson’s disease

    G. Carey, L. Defebvre, A. Moonen, A. Leentjens, K. Dujardin (Lille, France)

    Objective: To determine the demographic, clinical and cognitive features associated with anxiety disorders in Parkinson’s disease (PD). Background: The point prevalence of anxiety disorders in…
  • 2019 International Congress

    Progression of neuropsychiatric symptoms in Parkinson’s disease

    J. Dlay, G. Duncan, T. Khoo, C. Williams-Gray, D. Breen, R. Barker, D. Burn, R. Lawson, A. Yarnall (Newcastle Upon Tyne, United Kingdom)

    Objective: To determine the progression of neuropsychiatric symptoms (NPS) in Parkinson’s disease (PD) and their associations with quality of life (QoL) and motor problems. Background:…
  • 2019 International Congress

    Defence Mechanism of Ego and Coping Strategy Style of the Patient with Parkinson’s Disease

    M. Kulsum, S. Choudhury, A. Ghosh, P. Ghosh (Kolkata, India)

    Objective: To find out the prevalence of different defence mechanism and coping strategies in the patients with PD.To find out the relationship between using of…
  • 2018 International Congress

    Dopaminergic impairments following repeated exposure to stress on the neurotoxicity of lambda-cyhalothrin through inflammatory cytokines in rats

    R. Shukla, R. Gupta, S. Goel, A. Pant, V. Khanna (Bhopal, India)

    Objective: Impact of psychological stressors in modulating the toxicity of environmental chemicals has been suggested, however the mechanism this is not clear. Background: Repeated stress…
  • 2018 International Congress

    Neuromodulatory properties of flavonoids from Persea americana Peel: Role in CNS redox homeostasis and neurobehavioral markers

    S. Grace SR, PR, J. Chauhan, G. Chandran (Mys, India)

    Objective: Isolating flavonoids from Peel of Persea americana fruits & testing their effects on CNS redox homeostasis culminating in neurobehavioural amelioration among rats. Background: Cellular…
  • 2018 International Congress

    Effects of the Lee Silverman Voice Treatment (LSVT LOUD ®) on Facial Expressivity in Individuals with Parkinson’s Disease (PD) as a function of Emotional Valence

    A. Bono, K. Scorpio, R. Stafford, M. Halfacre, E. Murray, J. Twaite, K. Alterescu, J. Spielman, A. Halpern, L. Ramig, J. Borod (Flushing, NY, USA)

    Objective: To examine the effect of LSVT LOUD (Ramig et al., 2011) on facial expressivity in PD as a function of emotional valence. Background: Research…
  • 2018 International Congress

    Is early onset ataxia phenotypically discernible from developmental disorders with impaired coordination?

    T. Lawerman, R. Brandsma, N. Maurits, O. Martinez-Manzanera, R. Lunsing, R. Brouwer, H. Kremer, D. Sival (Groningen, Netherlands)

    Objective: To investigate: 1. the diagnostic accuracy of phenotypic Early Onset Ataxia (EOA) recognition among other pediatric disorders with impaired coordination (developmental coordination disorder (DCD)…
  • 2018 International Congress

    VIT-D and Tics Movement Disorder

    N. Gemawat (Mumbai, India)

    Objective: Tics is common childhood movement disorder, with classified variants , typically begin at around 4-5 years of age but often present later at about…
  • 2018 International Congress

    Telepsychiatry for Patients with Parkinson’s disease

    M. Heiry, N. Galifianakis, J. Ostrem, A. Seritan (San Francisco, CA, USA)

    Objective: To demonstrate the feasibility of telemedicine for treatment of psychiatric co-morbidities in Parkinson’s disease and evaluate patient satisfaction with telepsychiatry. Background: Parkinson’s disease (PD)…
  • 2018 International Congress

    Neuropsychological characteristics of children with tremor

    S. O'Shea, W. Garcia, E. Louis, R. Alcalay, V. Rauh (New York, NY, USA)

    Objective: To test if otherwise healthy children with tremor have neuropsychological impairment. Background: Tremor in children has not been as widely studied as tremor in…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley